The research proposal ELMUMY (Elucidation of Risk Factors and Health Determinants Associated with Progression of Monoclonal Gammopathies to Multiple Myeloma), submitted in the framework of the Horizon Europe Call: HORIZON-MISS-2021-Cancer-02, has been selected for funding by the European Commission, having received the…
The session has ended for security reasons.